Descrizione del progetto
Una piattaforma TIC innovativa per l’autogestione del diabete
Il diabete è una malattia in rapida diffusione che colpisce una parte significativa della popolazione europea, causando morte, amputazioni, cecità e insufficienza renale. Rappresenta un onere significativo per la società e l’economia. Il progetto ProEmpower, finanziato dall’UE, mira a ottenere una soluzione TIC integrata per l’autogestione di questa malattia. Attraverso 10 aree d’azione, cerca di raggiungere risultati ottimali per la salute. La piattaforma innovativa e interoperabile del progetto fornirà un accesso sicuro ai dispositivi e alle cartelle cliniche necessari, consentendo la diagnosi precoce, il supporto decisionale personalizzato, l’autogestione e il supporto dei pari. Implementando il modello di assistenza per le malattie croniche, il progetto intende rispondere alle esigenze specifiche del diabete di tipo 2 in tutte le sue fasi, responsabilizzando le persone attraverso linee guida personalizzate e un uso efficiente dei dati clinici.
Obiettivo
Public procurers in ProEmpower aim to procure a disease self-management solution to help meet the imminent threat of a diabetes epidemic. ProEmpower will make person-centred care reality - giving the patient the steering wheel - for optimal health outcomes. Very significant synergies will be reaped by supporting all 10 action areas of diabetes management in an integrated ICT solution. Early detection, personal decision support, self management and peer support are to be delivered from a platform with full interoperable and secure access to the necessary devices and health records. ProEmpower will apply the internationally acclaimed Chronic Care Model to specify support needs for type 2 diabetes at all stages. Self-management and treatment will be supported by personalised guidelines and making the best use of clinical data. In this way a quality culture in healthcare will be fostered and learning healthcare systems made reality.
Suppliers will be rigorously evaluated after each of the four procurement phases, comprising (I) an open market consultation supported by the European eHealth Competition, (II) specification of architecture and system aligned to requirements of patients, peers and providers, (III) prototype development and testing with end-users and (IV) effectiveness proven in a trial with 200 patients and 40 professionals.
Fully rolled out in the four countries, enabled by procurers with the authority and capacity in their countries and regions, ProEmpower will serve 12 million diabetes patients.
Reductions in diabetes-related death, amputation, blindness and renal failure promise cost relief of € 53 billion over 7 years in the four countries. Suppliers can expect a turnover of € 5 billion a year. Proven ability to cover the four different health systems promises ProEmpower suppliers easy entry into other EU markets and beyond, a very strong contribution to overcoming fragmentation of demand and fostering the global market.
Campo scientifico
Programma(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SC1-2016-CNECT
Meccanismo di finanziamento
PCP - Pre-Commercial ProcurementCoordinatore
06434 Ankara
Turchia